Tocqueville Asset Management L.P. Atara Biotherapeutics, Inc. Transaction History

Tocqueville Asset Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$19.05 - $41.04 $417,671 - $899,802	-21,925 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$28.4 - $41.74 $286,840 - $421,574	10,100 Added 85.41%	21,925 $872,000
Q4 2018 Feb 08, 2019	BUY	$30.9 - $42.97 $30,900 - $42,970	1,000 Added 9.24%	11,825 $411,000
Q3 2018 Nov 13, 2018	BUY	$35.05 - $43.5 $35,050 - $43,500	1,000 Added 10.18%	10,825 $448,000
Q2 2018 Aug 13, 2018	BUY	$35.15 - $51.45 $45,695 - $66,885	1,300 Added 15.25%	9,825 $361,000
Q1 2018 May 14, 2018	BUY	$18.0 - $48.35 $153,450 - $412,183	8,525 New	8,525 $332,000

3.07M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $762M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.